Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE−/− mice

Atherosclerosis

Volumn 255, Issue , 2016, Pages 164-170

  Fuijkschot, Wessel W ^a,b   Morrison, Martine C ^c   van der Linden, Rianne ^a   Krijnen, Paul A J ^a,b   Zethof, Ilse P A ^a   Theyse, Lars F H ^d   Kleemann, Robert ^c,e   Niessen, Hans W M ^a,b   Smulders, Yvo M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal model; Atherosclerosis; Inflammation; Myocardial infarction; Surgery

Indexed keywords

APOLIPOPROTEIN E; PARAFFIN; SERUM AMYLOID A; SODIUM CHLORIDE; AUTACOID; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CELL DEATH; CELL DENSITY; CONTROLLED STUDY; FEMORAL SHAFT; FEMUR OSTEOTOMY; INFLAMMATION; INFLAMMATORY CELL; KIRSCHNER WIRE; LYMPHOCYTE; MACROPHAGE; MAST CELL; MOUSE; NECROSIS; NEUTROPHIL; NONHUMAN; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; WESTERN DIET; ANIMAL; AORTA; AORTIC DISEASE; BLOOD; BLOOD VESSEL CALCIFICATION; DEFICIENCY; DISEASE COURSE; DISEASE MODEL; FEMUR; FIBROSIS; GENETIC PREDISPOSITION; GENETICS; KNOCKOUT MOUSE; LIPID DIET; METABOLISM; OSTEOTOMY; PATHOLOGY; PHENOTYPE; SURGERY; TIME FACTOR;

ANIMALS; AORTA; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOMARKERS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMUR; FIBROSIS; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATION; INFLAMMATION MEDIATORS; MICE, KNOCKOUT; NECROSIS; OSTEOTOMY; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; SERUM AMYLOID A PROTEIN; TIME FACTORS; VASCULAR CALCIFICATION;

EID: 84999885210     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.07.909     Document Type: Article

References (31)

1. [1] Smeeth, L., Thomas, S.L., Hall, A.J., Hubbard, R., Farrington, P., Vallance, P., Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 351:25 (2004 December 16), 2611–2618.
2. [2] Lalmohamed, A., Vestergaard, P., Klop, C., et al. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch. Intern Med. 172:16 (2012 September 10), 1229–1235.
3. [3] Corrales-Medina, V.F., Musher, D.M., Wells, G.A., Chirinos, J.A., Chen, L., Fine, M.J., Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 125:6 (2012 February 14), 773–781.
4. [4] Cohen, M.C., Aretz, T.H., Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol. 8:3 (1999 May), 133–139.
5. [5] Hanson, I., Kahn, J., Dixon, S., Goldstein, J., Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction. Catheter Cardiovasc Interv. 82:4 (2013 October 1), 622–628.
6. [6] Gualandro, D.M., Campos, C.A., Calderaro, D., et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis 222:1 (2012 May), 191–195.
7. [7] Janssen, H., Wagner, C.S., Demmer, P., et al. Acute perioperative stress-induced increase of plaque volume and vulnerability in apolipoprotein E-deficient mice is amenable to statin treatment and IL-6-inhibition. Dis. Model Mech. 8:9 (2015 Sept), 1071–1080.
8. [8] Libby, P., Inflammation in atherosclerosis. Nature 420:6917 (2002 December 19), 868–874.
9. [9] Virmani, R., Burke, A.P., Kolodgie, F.D., Farb, A., Vulnerable plaque: the pathology of unstable coronary lesions. J. Interv. Cardiol. 15:6 (2002 December), 439–446.
10. [10] Virmani, R., Burke, A.P., Farb, A., Kolodgie, F.D., Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 47:8 Suppl (2006 April 18), C13–C18.
11. [11] Santos-Gallego, C.G., Picatoste, B., Badimon, J.J., Pathophysiology of acute coronary syndrome. Curr. Atheroscler. Rep., 16(4), 2014 April, 401.
12. [12] Thompson, J.C., Jayne, C., Thompson, J., et al. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J. Lipid Res. 56:2 (2015 February), 286–293.
13. [13] Reid, D., Toole, B.J., Knox, S., et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am. J. Clin. Nutr. 93:5 (2011 May), 1006–1011.
14. [14] Morrison, M., van der Heijden, R., Heeringa, P., et al. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFkappaB in vivo. Atherosclerosis 233:1 (2014 March), 149–156.
15. [15] Seimon, T.A., Wang, Y., Han, S., et al. Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. J. Clin. Investig. 119:4 (2009 April), 886–898.
16. [16] Kleemann, R., Zadelaar, S., Kooistra, T., Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 79:3 (2008 August 1), 360–376.
17. [17] Zhang, N., Ahsan, M.H., Purchio, A.F., West, D.B., Serum amyloid A-luciferase transgenic mice: response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition. J. Immunol. 174:12 (2005 June 15), 8125–8134.
18. [18] King, V.L., Thompson, J., Tannock, L.R., Serum amyloid A in atherosclerosis. Curr. Opin. Lipidol. 22:4 (2011 August), 302–307.
19. [19] Thompson, J.C., Jayne, C., Thompson, J., et al. A brief elevation of serum amyloid A is sufficient to increase atherosclerosis. J. Lipid Res. 8:9 (2014 Feb), 286–290.
20. [20] Tan, S.Z., Ooi, D.S., Shen, H.M., Heng, C.K., The atherogenic effects of serum amyloid A are potentially mediated via inflammation and apoptosis. J. Atheroscler. Thromb. 21:8 (2014), 854–867.
21. [21] Santos-Gallego, C.G., Badimon, J.J., Rosenson, R.S., Beginning to understand high-density lipoproteins. Endocrinol. Metab. Clin. North Am. 43:4 (2014 December), 913–947.
22. [22] Dutta, P., Courties, G., Wei, Y., et al. Myocardial infarction accelerates atherosclerosis. Nature 487:7407 (2012 July 19), 325–329.
23. [23] van Dijk, R.A., Virmani, R., von der Thusen, J.H., Schaapherder, A.F., Lindeman, J.H., The natural history of aortic atherosclerosis: a systematic histopathological evaluation of the peri-renal region. Atherosclerosis 210:1 (2010 May), 100–106.
24. [24] Moore, K.J., Sheedy, F.J., Fisher, E.A., Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13:10 (2013 October), 709–721.
25. [25] Kaynar, A.M., Yende, S., Zhu, L., et al. Effects of intra-abdominal sepsis on atherosclerosis in mice. Crit. Care, 18(5), 2014, 469.
26. [26] Naghavi, M., Wyde, P., Litovsky, S., et al. Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 107:5 (2003 February 11), 762–768.
27. [27] Landesberg, G., Beattie, W.S., Mosseri, M., Jaffe, A.S., Alpert, J.S., Perioperative myocardial infarction. Circulation 119:22 (2009 June 9), 2936–2944.
28. [28] Dutta, P., Courties, G., Wei, Y., et al. Myocardial infarction accelerates atherosclerosis. Nature 487:7407 (2012 July 19), 325–329.
29. [29] Santos-Gallego, C.G., Badimon, J.J., The sum of two evils: pneumonia and myocardial infarction: is platelet activation the missing link?. J. Am. Coll. Cardiol. 64:18 (2014 November 4), 1926–1928.
30. [30] Chen, Y.C., Bui, A.V., Diesch, J., et al. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ. Res. 113:3 (2013 July 19), 252–265.
31. [31] Van der Donckt, C., Van Herck, J.L., Schrijvers, D.M., et al. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur. Heart J. 36:17 (2015 May 1), 1049–1058.